REVOLUTION MEDICINES INC (RVMD) Stock Price, Quote, News and Overview
NASDAQ:RVMD - Nasdaq - US76155X1000 - Common Stock - Currency: USD
RVMD Quote, Performance and Key Statistics
41.34
-0.92 (-2.18%)
The current stock price of RVMD is 41.34 USD. In the past month the price increased by 0.49%. In the past year, price increased by 39%.
RVMD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About RVMD
Company Profile
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. The company is headquartered in Redwood City, California and currently employs 490 full-time employees. The company went IPO on 2020-02-13. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. Its RAS Companion Inhibitors are designed primarily for combination treatment strategies centered on its RAS(ON) Inhibitors. The Company’s RAS(ON) Inhibitors RMC-6236 RMC-6291 and RMC-9805 are in clinical development. RMC-6236, its RASMULTI(ON) inhibitor, is designed as a potent, oral, RAS-selective tri-complex inhibitor of multiple RAS(ON) variants, including cancer drivers.
Company Info
REVOLUTION MEDICINES INC
700 Saginaw Dr
Redwood City CALIFORNIA 94063 US
CEO: Mark A. Goldsmith
Employees: 490
Company Website: https://www.revmed.com/
Investor Relations: https://ir.revmed.com/
Phone: 14157663638
REVOLUTION MEDICINES INC / RVMD FAQ
What is the stock price of REVOLUTION MEDICINES INC today?
The current stock price of RVMD is 41.34 USD. The price decreased by -2.18% in the last trading session.
What is the ticker symbol for REVOLUTION MEDICINES INC stock?
The exchange symbol of REVOLUTION MEDICINES INC is RVMD and it is listed on the Nasdaq exchange.
On which exchange is RVMD stock listed?
RVMD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for REVOLUTION MEDICINES INC stock?
21 analysts have analysed RVMD and the average price target is 74.75 USD. This implies a price increase of 80.82% is expected in the next year compared to the current price of 41.34. Check the REVOLUTION MEDICINES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is REVOLUTION MEDICINES INC worth?
REVOLUTION MEDICINES INC (RVMD) has a market capitalization of 7.62B USD. This makes RVMD a Mid Cap stock.
How many employees does REVOLUTION MEDICINES INC have?
REVOLUTION MEDICINES INC (RVMD) currently has 490 employees.
What are the support and resistance levels for REVOLUTION MEDICINES INC (RVMD) stock?
REVOLUTION MEDICINES INC (RVMD) has a support level at 40.78 and a resistance level at 42.84. Check the full technical report for a detailed analysis of RVMD support and resistance levels.
Is REVOLUTION MEDICINES INC (RVMD) expected to grow?
The Revenue of REVOLUTION MEDICINES INC (RVMD) is expected to decline by -97.49% in the next year. Check the estimates tab for more information on the RVMD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy REVOLUTION MEDICINES INC (RVMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RVMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RVMD, evaluating the profitability, health, valuation and growth aspects
- REVOLUTION MEDICINES INC (RVMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- REVOLUTION MEDICINES INC (RVMD) Sales and EPS estimates to see what analysts future expectations are.
- REVOLUTION MEDICINES INC (RVMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- REVOLUTION MEDICINES INC (RVMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- REVOLUTION MEDICINES INC (RVMD) Stock Chart to make your own analysis
- REVOLUTION MEDICINES INC (RVMD) Latest news and press-releases to stay up to date.
Does REVOLUTION MEDICINES INC (RVMD) stock pay dividends?
RVMD does not pay a dividend.
When does REVOLUTION MEDICINES INC (RVMD) report earnings?
REVOLUTION MEDICINES INC (RVMD) will report earnings on 2025-02-26, after the market close.
What is the Price/Earnings (PE) ratio of REVOLUTION MEDICINES INC (RVMD)?
REVOLUTION MEDICINES INC (RVMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.59).
What is the Short Interest ratio of REVOLUTION MEDICINES INC (RVMD) stock?
The outstanding short interest for REVOLUTION MEDICINES INC (RVMD) is 8.85% of its float. Check the ownership tab for more information on the RVMD short interest.
RVMD Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to RVMD. When comparing the yearly performance of all stocks, RVMD turns out to be only a medium performer in the overall market: it outperformed 66.2% of all stocks.
RVMD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RVMD. No worries on liquidiy or solvency for RVMD as it has an excellent financial health rating, but there are worries on the profitability.
RVMD Financial Highlights
Over the last trailing twelve months RVMD reported a non-GAAP Earnings per Share(EPS) of -3.59. The EPS decreased by -10.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -32.16% | ||
| ROE | -36.2% | ||
| Debt/Equity | 0 |
RVMD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 89% to RVMD. The Buy consensus is the average rating of analysts ratings from 21 analysts.
For the next year, analysts expect an EPS growth of 6.07% and a revenue growth -97.49% for RVMD